CAPPETTA, Donato
 Distribuzione geografica
Continente #
EU - Europa 985
NA - Nord America 848
AS - Asia 141
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.986
Nazione #
US - Stati Uniti d'America 846
IE - Irlanda 370
IT - Italia 287
DE - Germania 88
GB - Regno Unito 84
UA - Ucraina 67
CN - Cina 66
SG - Singapore 39
FI - Finlandia 23
GR - Grecia 22
TR - Turchia 15
BE - Belgio 13
SE - Svezia 11
SC - Seychelles 10
VN - Vietnam 10
FR - Francia 7
JP - Giappone 6
NL - Olanda 6
CZ - Repubblica Ceca 4
DK - Danimarca 2
IN - India 2
PR - Porto Rico 2
ES - Italia 1
EU - Europa 1
IR - Iran 1
KR - Corea 1
TH - Thailandia 1
UY - Uruguay 1
Totale 1.986
Città #
Dublin 365
Chandler 207
Jacksonville 114
Naples 82
Ann Arbor 53
Caserta 48
Bremen 42
Princeton 42
Roxbury 38
New York 28
Singapore 25
Medford 24
Beijing 23
Napoli 23
Cambridge 20
Wilmington 16
Woodbridge 15
Des Moines 14
Brussels 13
Ashburn 12
Boardman 12
Aversa 10
Dong Ket 10
Dearborn 8
Hanover 8
Munich 8
Avellino 7
Düsseldorf 7
Auburn Hills 6
Campofelice di Roccella 6
Fasano 6
Nanjing 6
San Giorgio a Cremano 6
Torre Annunziata 6
Amsterdam 5
Hefei 5
Jinan 5
Tokyo 5
Brno 4
Helsinki 4
Lanzhou 4
San Mateo 4
Seattle 4
Houston 3
Los Angeles 3
Marsico Nuovo 3
Redwood City 3
Rome 3
Shenyang 3
Antea 2
Frattamaggiore 2
Giugliano In Campania 2
Juelsminde 2
Lappeenranta 2
London 2
Milan 2
Mountain View 2
Portici 2
Salerno 2
Turin 2
Valenza 2
Bari 1
Battipaglia 1
Brusciano 1
Cerveteri 1
Conegliano 1
Duncan 1
Ferrara 1
Geislingen an der Steige 1
Groningen 1
Haikou 1
Harbin 1
Madrid 1
Minneapolis 1
Montesarchio 1
Montesilvano Marina 1
Montevideo 1
Nanchang 1
Navi Mumbai 1
Nola 1
Norwalk 1
Parma 1
Perugia 1
Pirogov 1
Pomigliano d'Arco 1
Porto Torres 1
Pozzuoli 1
Quzhou 1
Sant'Antimo 1
Shanghai 1
Tianjin 1
Torino 1
Venice 1
Villa di Briano 1
Zhengzhou 1
Totale 1.426
Nome #
Dipeptidyl peptidase 4 inhibitor sitagliptin reduces oxidative stress, endothelial dysfunction and preserves diastolic function in a rat model of heart failure with preserved ejection fraction 86
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 85
Chronic exposure to low dose of bisphenol A impacts on the first round of spermatogenesis via SIRT1 modulation. 75
Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension 73
Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity 67
Intratracheal administration of mesenchymal stem cells modulates tachykinin system, suppresses airway remodeling and reduces airway hyperresponsiveness in an animal model 66
c-kit Haploinsufficiency impairs adult cardiac stem cell growth, myogenicity and myocardial regeneration 64
Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction 60
Doxorubicin induces senescence and impairs function of human cardiac progenitor cells 59
C-reactive protein and carotid intima-media thickness in children with sleep disordered breathing. 57
Rosiglitazone Reduces the Inflammatory Response in a Model of Vascular Injury in Rats 57
MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat 57
Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction 57
Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity 54
Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. 53
Doxorubicin targets multiple players: A new view of an old problem 52
New Role of Adult Lung c-kit+ Cells in a Mouse Model of Airway Hyperresponsiveness 51
Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction 50
Recumbent deoxygenation in mild/moderate liver cirrhosis: the "Clinodeoxia". The ortho-clino paradigm. 49
Doxorubicin cardiotoxicity and target cells: a broader perspective 48
Atrial fibrillation: epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors 46
Adrenoceptor blockers: influence on depression and anxiety 46
Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome 45
Deficit of glucocorticoid-induced leucine zipper amplifies angiotensin-induced cardiomyocyte hypertrophy and diastolic dysfunction 45
Lung Mesenchymal Stem Cells Ameliorate Elastase-Induced Damage in an Animal Model of Emphysema 44
SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy 43
Diabetes-Induced Cellular Senescence and Senescence-Associated Secretory Phenotype Impair Cardiac Regeneration and Function Independently of Age 41
Cytochalasin D restores nuclear size acting on F-actin and IZUMO1 localization in low-quality spermatozoa 39
Resveratrol attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of doxorubicin cardiomyopathy 38
Doxorubicin cardiotoxicity: multiple targets and translational perspectives 38
Current and future therapeutic perspective in chronic heart failure 38
In vitro CSC-derived cardiomyocytes exhibit the typical microRNA-mRNA blueprint of endogenous cardiomyocytes 36
c-Kit-positive cardiac stem cells nested in hypoxic niches are activated by stem cell factor reversing the aging myopathy 35
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 31
SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells 30
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 30
Anthracycline cardiotoxicity: New actors on the stage 30
Human cardiac progenitor cells with regenerative potential can be isolated and characterized from 3D-electro-anatomic guided endomyocardial biopsies 29
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary 26
Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial 26
Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch 22
COVID-19 and atrial fibrillation: Intercepting lines 22
Statins stimulate new myocyte formation after myocardial infarction by activating growth and differentiation of the endogenous cardiac stem cells 18
FUS driven circCNOT6L biogenesis in mouse and human spermatozoa supports zygote development 18
Sodium-Glucose Cotransporter 2 Inhibitors and Heart Failure: A Bedside-to-Bench Journey 15
Ranolazine Counteracts Strength Impairment and Oxidative Stress in Aged Sarcopenic Mice 15
Immunohistochemical analysis of cardiac tissue 14
Le cellule staminali nella terapia cellulare cardiaca 13
Mechanical Stress Regulates Endothelial Progenitor Cell Angiogenesis Through VEGF Receptor Endocytosis 12
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database 11
Glucocorticoid-induced leucine zipper (Gilz) in cardiovascular health and disease 11
Correction: c-kit Haploinsufficiency impairs adult cardiac stem cell growth, myogenicity and myocardial regeneration 4
Totale 2.131
Categoria #
all - tutte 9.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020203 38 32 7 5 24 6 29 16 15 9 15 7
2020/2021222 21 7 21 6 35 11 35 12 9 12 36 17
2021/2022252 5 3 5 8 65 9 8 10 9 6 28 96
2022/2023790 49 22 31 63 80 65 14 46 366 12 19 23
2023/2024354 21 17 33 14 99 56 7 12 6 7 16 66
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 2.131